evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract
19585,GENE_BACKGROUND,,"GATA2 encodes the GATA binding protein 2 transcription factor. GATA2 is involved in hematopoiesis and differentiation, including stem cell maintenance and cell specification (PMID:8078582, 12433372, 25578878, 20887958). It is also involved in angiogenesis and lymphangiogenesis (PMID:23892628). Inherited GATA2 mutations are associated with familial myelodysplastic syndrome and acute myeloid leukemia (AML) (PMID:21892162). Mutations are also associated with a heritable lymphedema disorder, Emberger syndrome, with a disposition to AML (PMID:21892158). It is also found in patients with MonoMAC syndrome, an immunodeficiency disorder predisposed to select infectious agents (PMID:21670465). Somatic GATA2 mutations are found in leukemias and often co-occur with CEBPA mutations (PMID:23634996,22649106, 23521373,18250304). Inversion 3 leukemias involve dysregulation of GATA2 and EV1 by translocation of a GATA2 enhancer that regulates gene expression (PMID:24703711). In lung cancer, GATA2 was shown to regulate Ras signaling (PMID:22541434). In prostate cancer and other tumors, GATA2 can promote resistance and metastasis (PMID:25670080, 24448395, 25707769).",,2017-01-17,,2624,GATA2,GATA binding protein 2,False,ENST00000341105,NM_032638.4,DCML,MONOMAC,NFE1B,IMD21,False,23634996,Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.,The New England journal of medicine,2018-05-30T20:13:00,368,22,2059-74,Cancer Genome Atlas Research Network. et al,doi: 10.1056/NEJMoa1301689,,0001-05-30,,23521373,CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosis.,British journal of haematology,2018-06-01T20:13:00,161,5,649-58,Grossmann V et al,doi: 10.1111/bjh.12297,,0001-06-01,,21670465,Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.,Blood,2018-09-08T20:11:00,118,10,2653-5,Hsu AP et al,doi: 10.1182/blood-2011-05-356352,,0001-09-08,,25670080,A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer.,Cancer cell,2018-02-09T20:15:00,27,2,223-39,Vidal SJ et al,doi: 10.1016/j.ccell.2014.11.013,,0001-02-09,,20887958,Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators.,Cell stem cell,2018-10-08T20:10:00,7,4,532-44,Wilson NK et al,doi: 10.1016/j.stem.2010.07.016,,0001-10-08,,22649106,GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.,Blood,2018-07-12T20:12:00,120,2,395-403,Greif PA et al,doi: 10.1182/blood-2012-01-403220,,2018-07-12T04:03:00,,24448395,GATA2 as a potential metastasis-driving gene in prostate cancer.,Oncotarget,2018-01-30T20:14:00,5,2,451-61,Chiang YT et al,,,0001-01-30,,21892158,Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome).,Nature genetics,2018-09-04T20:11:00,43,10,929-31,Ostergaard P et al,doi: 10.1038/ng.923,,0001-09-04,,24703711,A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.,Cell,2018-04-10T20:14:00,157,2,369-381,Gröschel S et al,doi: 10.1016/j.cell.2014.02.019,,0001-04-10,,12433372,Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates.,Immunity,2018-11-01T20:02:00,17,5,665-76,Walsh JC et al,,,0001-11-01,,23892628,GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.,Angiogenesis,2018-10-01T20:13:00,16,4,939-52,Coma S et al,doi: 10.1007/s10456-013-9370-9,,0001-10-01,,21892162,Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.,Nature genetics,2018-09-04T20:11:00,43,10,1012-7,Hahn CN et al,doi: 10.1038/ng.913,,0001-09-04,,25707769,GATA2 promotes glioma progression through EGFR/ERK/Elk-1 pathway.,"Medical oncology (Northwood, London, England)",2018-04-01T20:15:00,32,4,87,Wang Z et al,doi: 10.1007/s12032-015-0522-1,,0001-04-01,,25578878,Developmental control of polycomb subunit composition by GATA factors mediates a switch to non-canonical functions.,Molecular cell,2018-01-22T20:15:00,57,2,304-316,Xu J et al,doi: 10.1016/j.molcel.2014.12.009,,2018-01-22T03:16:00,,18250304,Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia.,Proceedings of the National Academy of Sciences of the United States of America,2018-02-12T20:08:00,105,6,2076-81,Zhang SJ et al,doi: 10.1073/pnas.0711824105,,0001-02-12,,8078582,An early haematopoietic defect in mice lacking the transcription factor GATA-2.,Nature,0001-09-15,371,6494,221-6,Tsai FY et al,,,0001-09-15,,22541434,The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer.,Cell,2018-04-27T20:12:00,149,3,642-55,Kumar MS et al,doi: 10.1016/j.cell.2012.02.059,,0001-04-27,
19584,GENE_SUMMARY,,GATA2 encodes a transcription factor involved in red blood cell and platelet development. Germline mutations of GATA2 are associated with Emberger and MonoMAC syndromes and predispose to leukemias.,,2017-01-17,,2624,GATA2,GATA binding protein 2,False,ENST00000341105,NM_032638.4,DCML,MONOMAC,NFE1B,IMD21,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
